As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published Monday in JAMA Network, among the 25,531 participants, 8,504 were eligible for semaglutide. Semaglutide, the active medicine found in the drug, has become a popular option for people looking to lose weight. Ozempic, along with Wegovy, has been widely used, and both medicines are also used for the treatment of Type 2 diabetes. Among eligible adults, the mean age is 50.7 years old, and 49 percent are women. The study used data from the National Health and Nutrition Examination Survey to identify eligible adults. Although most of the Americans who are eligible
Hence then, the article about researchers estimate 136m americans eligible for ozempic was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Researchers estimate 136M Americans eligible for Ozempic )